SK287865B6 - Hirudin precursor comprising signal sequence, method for the preparation of Leu-hirudin and use of precursor - Google Patents

Hirudin precursor comprising signal sequence, method for the preparation of Leu-hirudin and use of precursor Download PDF

Info

Publication number
SK287865B6
SK287865B6 SK362-2002A SK3622002A SK287865B6 SK 287865 B6 SK287865 B6 SK 287865B6 SK 3622002 A SK3622002 A SK 3622002A SK 287865 B6 SK287865 B6 SK 287865B6
Authority
SK
Slovakia
Prior art keywords
hirudin
leu
sequence
precursor
artificial sequence
Prior art date
Application number
SK362-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK3622002A3 (en
Inventor
Paul Habermann
Rudolf Bender
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of SK3622002A3 publication Critical patent/SK3622002A3/sk
Publication of SK287865B6 publication Critical patent/SK287865B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK362-2002A 1999-09-18 2000-09-01 Hirudin precursor comprising signal sequence, method for the preparation of Leu-hirudin and use of precursor SK287865B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944870A DE19944870A1 (de) 1999-09-18 1999-09-18 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
PCT/EP2000/008537 WO2001021662A1 (de) 1999-09-18 2000-09-01 Signalsequenzen zur herstellung von leu-hirudin über sekretion durch e. coli in das kulturmedium

Publications (2)

Publication Number Publication Date
SK3622002A3 SK3622002A3 (en) 2003-06-03
SK287865B6 true SK287865B6 (sk) 2012-02-03

Family

ID=7922547

Family Applications (1)

Application Number Title Priority Date Filing Date
SK362-2002A SK287865B6 (sk) 1999-09-18 2000-09-01 Hirudin precursor comprising signal sequence, method for the preparation of Leu-hirudin and use of precursor

Country Status (29)

Country Link
US (1) US7455987B1 (tr)
EP (1) EP1216259B1 (tr)
JP (1) JP4669181B2 (tr)
KR (1) KR100737189B1 (tr)
CN (2) CN1269838C (tr)
AR (1) AR025660A1 (tr)
AT (1) ATE357458T1 (tr)
AU (1) AU775923B2 (tr)
BR (1) BR0014519A (tr)
CA (1) CA2385287C (tr)
CZ (1) CZ2002899A3 (tr)
DE (2) DE19944870A1 (tr)
DK (1) DK1216259T3 (tr)
EE (1) EE05187B1 (tr)
HK (2) HK1049172A1 (tr)
HR (1) HRP20020226B1 (tr)
HU (1) HUP0202596A3 (tr)
IL (2) IL148624A0 (tr)
ME (1) MEP27908A (tr)
MX (1) MXPA02002469A (tr)
NO (1) NO329723B1 (tr)
NZ (1) NZ517825A (tr)
PL (1) PL205117B1 (tr)
RS (1) RS50435B (tr)
RU (1) RU2261867C2 (tr)
SK (1) SK287865B6 (tr)
TR (2) TR200501541T2 (tr)
WO (1) WO2001021662A1 (tr)
ZA (1) ZA200202106B (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
JP5028551B2 (ja) 2003-11-21 2012-09-19 フェネックス インコーポレイテッド Ｓｅｃ系分泌によって改良された発現系
WO2006014899A2 (en) 2004-07-26 2006-02-09 Dow Global Technologies Inc. Process for improved protein expression by strain engineering
DE102005046113A1 (de) * 2005-09-27 2007-03-29 Sanofi-Aventis Deutschland Gmbh Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen
DE102006044841A1 (de) * 2006-09-22 2008-04-03 Wacker Chemie Ag Signalpeptid zur Produktion von rekombinanten Proteinen
AU2008210538B2 (en) 2007-01-31 2013-06-06 Pelican Technology Holdings, Inc. Bacterial leader sequences for increased expression
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
ES2853935T3 (es) 2013-03-12 2021-09-20 Massachusetts Gen Hospital Proteínas modificadas de sustancia inhibidora muleriana (MIS) y usos de las mismas para el tratamiento de enfermedades
CA2933335A1 (en) 2013-12-11 2015-06-18 The General Hospital Corporation Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation
CN108220369B (zh) * 2017-12-04 2021-03-12 广东双骏生物科技有限公司 一种生产重组水蛭素的方法
CN108359689B (zh) * 2018-01-19 2021-03-23 华中农业大学 利用抗病基因识别无毒效应蛋白以鉴定具有分泌功能信号肽的方法
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
ATE87938T1 (de) * 1985-04-11 1993-04-15 Hoechst Ag Hirudin-derivat.
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
AU648124B2 (en) * 1990-11-08 1994-04-14 Japan Energy Corporation Hirudine mutant, production thereof, anticoagulant, secretory vector, microorganism transformed by said vector, and production of product from said microorganism
JPH07119237B2 (ja) * 1990-11-08 1995-12-20 株式会社ジャパンエナジー ヒルジン変異体，その製造法及び抗凝血剤
PT100580A (pt) * 1991-06-12 1993-09-30 Regeneron Pharma Producao e recuperacao de neurotrofinas recombinantes
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
DE4140381A1 (de) 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet

Also Published As

Publication number Publication date
HRP20020226B1 (en) 2010-08-31
AU775923B2 (en) 2004-08-19
NO329723B1 (no) 2010-12-06
NZ517825A (en) 2004-07-30
US7455987B1 (en) 2008-11-25
HRP20020226A2 (en) 2004-04-30
KR20020034188A (ko) 2002-05-08
DE19944870A1 (de) 2001-03-29
PL354444A1 (en) 2004-01-12
JP4669181B2 (ja) 2011-04-13
CZ2002899A3 (cs) 2002-06-12
ATE357458T1 (de) 2007-04-15
YU14602A (sh) 2005-07-19
CA2385287C (en) 2010-10-19
IL148624A (en) 2009-08-03
ZA200202106B (en) 2003-01-09
RU2261867C2 (ru) 2005-10-10
MEP27908A (en) 2010-10-10
AU6842100A (en) 2001-04-24
TR200200667T2 (tr) 2002-06-21
KR100737189B1 (ko) 2007-07-10
HK1068352A1 (en) 2005-04-29
HUP0202596A3 (en) 2005-01-28
NO20021254L (no) 2002-05-07
DE50014189D1 (de) 2007-05-03
RU2002110278A (ru) 2004-03-27
BR0014519A (pt) 2002-06-11
IL148624A0 (en) 2002-09-12
EE200200139A (et) 2003-06-16
EE05187B1 (et) 2009-06-15
WO2001021662A1 (de) 2001-03-29
CN1374970A (zh) 2002-10-16
EP1216259B1 (de) 2007-03-21
NO20021254D0 (no) 2002-03-13
MXPA02002469A (es) 2002-08-28
EP1216259A1 (de) 2002-06-26
AR025660A1 (es) 2002-12-11
TR200501541T2 (tr) 2005-06-21
CN1192037C (zh) 2005-03-09
DK1216259T3 (da) 2007-07-02
HK1049172A1 (en) 2003-05-02
HUP0202596A2 (hu) 2002-12-28
JP2003510041A (ja) 2003-03-18
CA2385287A1 (en) 2001-03-29
PL205117B1 (pl) 2010-03-31
CN1269838C (zh) 2006-08-16
CN1550502A (zh) 2004-12-01
RS50435B (sr) 2009-12-31
SK3622002A3 (en) 2003-06-03

Similar Documents

Publication Publication Date Title
SK287865B6 (sk) Hirudin precursor comprising signal sequence, method for the preparation of Leu-hirudin and use of precursor
US5292646A (en) Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5270181A (en) Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
JP4897792B2 (ja) 融合タンパク質の分離のための組成物および方法
JP3865792B2 (ja) ペプチド、融合ペプチド、発現ベクター及び組換えタンパク質の製造方法
US20170074858A1 (en) Stabilizied Bioactive Peptides and Methods of Identification, Synthesis and Use
JPH10507368A (ja) ヘテロローガスなポリペプチドを分泌させるための方法および組成物
WO1991017245A1 (en) Ubiquitin-specific protease
JPH07106157B2 (ja) ヒルジン誘導体、その取得法、組換えｄｎａ及び組換えベクター
JP2003511078A (ja) 複数のエピトープと融合した組換えタンパク質の精製
WO1988003171A1 (en) Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same
JP2504723B2 (ja) 組換体ｄｎａとこれを含むプラスミドベクタ―とこのような組換体ｄｎａを保持する大腸菌
AU777246B2 (en) Microbial protein expression system
JP2549504B2 (ja) Ｄｎａ塩基配列、ポリペプチド分泌発現ベクター及び形質転換微生物
JPH08103278A (ja) 活性型ヒトａｌｔの製造方法
KR940011339B1 (ko) 세린프로테아제억제제의 제조를 위한 dna 재조합 방법
CA2290716A1 (en) Fusion proteins comprising coiled-coil structures
JPH0740926B2 (ja) 形質転換体およびペプチド前駆体タンパク質の製造方法
JPH07213289A (ja) 神経栄養因子の遺伝子工学的大量生産方法
JPH0740924B2 (ja) 形質転換体および融合蛋白質の製造方法

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20120901